5 Best Stem Cell Therapy Stocks to Buy

Page 5 of 5

1. Thermo Fisher Scientific Inc. (NYSE:TMO)

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best stem cell therapy stocks to buy. On April 23, Thermo Fisher Scientific Inc. (NYSE:TMO) announced financial results for fiscal Q1 2026. Revenue for the quarter rose 6% to $11.01 billion, compared to $10.36 billion in the same quarter last year. Organic revenue underwent a 1% growth. Management further reported that the GAAP diluted EPS in fiscal Q1 2026 was $4.43, reflecting an 11% growth compared to the prior year period. GAAP operating income for the quarter reached $1.86 billion, up 9% versus the year-ago quarter, while GAAP operating margin was 16.9%, compared with 16.6% in fiscal Q1 2025.

Thermo Fisher Scientific Inc. (NYSE:TMO) also stated that it advanced its proven growth strategy, launching a range of high-impact and innovative products during the quarter. This included a Thermo Scientific™ Glacios™ 3 Cryo-TEM, the Thermo Scientific™ TSQ Certis™ triple quadrupole mass spectrometer, the Thermo Scientific™ Niton™ XL5e Handheld XRF Analyzer, and the Gibco™ CTS™ Compleo™ Fill and Finish System.

Thermo Fisher Scientific Inc. (NYSE:TMO) provides analytical instruments, reagents, equipment, software, and other services for analysis, research, diagnostics, and discovery. It operates through the Analytical Instruments, Life Sciences Solutions, Laboratory Products and Services, and Specialty Diagnostics segments.

While we acknowledge the potential of TMO to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than TMO and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 5 of 5